Smith & Nephew(SNN) - 2024 Q1 - Earnings Call Presentation

Smith Nephew Forward looking statements and non-IFRS measures ◊Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office. Mid c -single-digit growth in Orthopaedics and Sports Medicine & ENT, partially offset by expected negative growth in Advanced Wound Bioactives Q1 2024 Revenue Performance Growth by Business Unit* Sports Med & ENT $441m • Underlying revenue growth +2.9%, +2.2% reported Growth by Region* *Growth rates are versus Q1 2023. Business Unit and Regional growth figure ...